Patients an additional as emergency treatment
The patients who had an additional stent implanted as emergency treatment for their stent thrombosis were at an increased risk for cardiac death or recurrent thrombosis, Dutch researchers said on Saturday.
Heart stents are tiny metal devices that are inserted into the arteries to keep them from clogging up with damaging plaque which can lead to heart attack. Companies manufacturing such devices in the U.S. include Boston Scientific Corp., Johnson & Johnson and Medtronic Inc. A fourth company, Abbot Laboratories Inc. is expecting approval to enter the market in the near future.
The researchers, led by Dr. Jochem Wouter van Werkum, a cardiologist at St. Antonius Hospital in Nieuwegein in the Netherlands, analyzed 437 patients with various kinds of stents who had stent thrombosis between January 2004 and February 2007. They found that 74 of the patients, or about one in six, experienced multiple episodes of stent thrombosis. Sixty-one patients had two episodes, 12 had three episodes and one patient had four episodes. Read more » »
March 31st, 2008 | No Comments »